Emerging trends of BCG immunotherapy for bladder cancer in last decade: a bibliometric and visualization analysis

BackgroundOne of the milestones in bacterial-mediated therapy for cancer, Bacillus Calmette-Guerin (BCG) has been used to treat bladder cancer (BC) for more than 30 years. BCG immunotherapy is now the standard of care for high-grade non-muscle invasive bladder cancer (NMIBC) following transurethral...

Full description

Bibliographic Details
Main Authors: Xingfeng Chen, Fang He, Wenjin Zhang, Yao Fu, Zhiqin Cao
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1092969/full